NFE2L1 and hepatocellular carcinoma: Taken together, these results indicate that NFE2L1 is a key regulator of hepatoma cell invasiveness, and NDUFA9 depletion is an upstream driver of OXPHOS defect and NFE2L1 upregulation in HCC tumors.